AKT1 and breast cancer: To confirm whether ASR-600 affects other pro-survival signaling pathways apart from AR in CRPC, we examined AKT, mTOR, Estrogen receptor (ER), and Progesterone receptor (PR) expressions in prostate and breast cancer cell lines.